Optimizing the manufacture and delivery of significant amounts of therapeutically potent cells, extend today’s frontiers in the field of cell therapy and regenerative medicine.
Choosing the right platforms, vectors, a comprehensive approach and the right partners will help you in the quest to deliver a better patient outcome avoiding possible complications.
Leaders in the pharma and biotech industry, health care sector and life science researchers will get insights about the latest advances in:
- Regenerative medicine
- Gene editing platforms
- Tackling the critical limitations in developing CRISPR therapeutics
- And the lessons learned during this journey